Follow
Frank J DeFalco
Frank J DeFalco
Janssen Research & Development
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Characterizing treatment pathways at scale using the OHDSI network
G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ...
Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016
3612016
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
EA Voss, R Makadia, A Matcho, Q Ma, C Knoll, M Schuemie, FJ DeFalco, ...
Journal of the American Medical Informatics Association 22 (3), 553-564, 2015
3022015
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 …
PB Ryan, JB Buse, MJ Schuemie, F DeFalco, Z Yuan, PE Stang, JA Berlin, ...
Diabetes, Obesity and Metabolism 20 (11), 2585-2597, 2018
2212018
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: a retrospective cohort study
Z Yuan, FJ DeFalco, PB Ryan, MJ Schuemie, PE Stang, JA Berlin, ...
Diabetes, Obesity and Metabolism 20 (3), 582-589, 2018
1252018
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahao, ...
Nature communications 11 (1), 5009, 2020
932020
Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents
Y Wang, M Desai, PB Ryan, FJ DeFalco, MJ Schuemie, PE Stang, ...
Diabetes research and clinical practice 128, 83-90, 2017
892017
Increasing trust in real-world evidence through evaluation of observational data quality
C Blacketer, FJ Defalco, PB Ryan, PR Rijnbeek
Journal of the American Medical Informatics Association 28 (10), 2251-2257, 2021
722021
Multisite evaluation of a data quality tool for patient-level clinical data sets
V Huser, FJ DeFalco, M Schuemie, PB Ryan, N Shang, M Velez, RW Park, ...
EGEMs 4 (1), 2016
702016
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of …
L Wang, EA Voss, J Weaver, L Hester, Z Yuan, F DeFalco, MJ Schuemie, ...
Pharmacoepidemiology and drug safety 28 (12), 1620-1628, 2019
492019
Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019
DM Kern, MS Cepeda, F Defalco, M Etropolski
BMC psychiatry 20, 1-10, 2020
422020
An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza
E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahão, ...
MedRxiv, 2020
312020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study
E Burn, SC You, A Sena, K Kostka, H Abedtash, MTF Abrahão, A Alberga, ...
medRxiv, 2020
292020
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS
K Kostka, T Duarte-Salles, A Prats-Uribe, AG Sena, A Pistillo, S Khalid, ...
Clinical Epidemiology, 369-384, 2022
282022
Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure
FJ DeFalco, PB Ryan, M Soledad Cepeda
Health Services and Outcomes Research Methodology 13, 58-67, 2013
252013
Risk prediction for ischemic stroke and transient ischemic attack in patients without atrial fibrillation: a retrospective cohort study
Z Yuan, EA Voss, FJ DeFalco, G Pan, PB Ryan, D Yannicelli, C Nessel
Journal of Stroke and Cerebrovascular Diseases 26 (8), 1721-1731, 2017
162017
Reopening businesses and risk of COVID-19 transmission
A O’Donoghue, T Dechen, W Pavlova, M Boals, G Moussa, M Madan, ...
NPJ digital medicine 4 (1), 51, 2021
15*2021
Genomic identification of the TOR signaling pathway as a target of the plant alkaloid antofine in the phytopathogen Fusarium graminearum
C Mogg, C Bonner, L Wang, J Schernthaner, M Smith, D Desveaux, ...
MBio 10 (3), 10.1128/mbio. 00792-19, 2019
152019
Using the data quality dashboard to improve the EHDEN network
C Blacketer, EA Voss, F DeFalco, N Hughes, MJ Schuemie, M Moinat, ...
Applied Sciences 11 (24), 11920, 2021
142021
Phenotype algorithms for the identification and characterization of vaccine-induced thrombotic thrombocytopenia in real world data: a multinational network cohort study
A Shoaibi, GA Rao, EA Voss, A Ostropolets, MA Mayer, ...
Drug safety 45 (6), 685-698, 2022
112022
Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain
E Roel, A Pistillo, M Recalde, AG Sena, S Fernandez-Bertolin, M Aragon, ...
Cancer Epidemiology, Biomarkers & Prevention 30 (10), 1884-1894, 2021
112021
The system can't perform the operation now. Try again later.
Articles 1–20